Paediatric oral compounding: expert insights from a global study
Hospital Pharmacy Europe
JANUARY 16, 2025
Here, lead author and focus group chair Hala Fadda discusses the reasons for widespread off-label prescribing, the FIP studys rationale and main findings, compounding challenges and considerations for improving clinical practice. Some APIs are only available as coated or modified release dosage forms, adding to the complexity of compounding.
Let's personalize your content